AdvaMed Statement on the Fiscal Cliff and Device Tax
WASHINGTON – Stephen J. Ubl, president and CEO of AdvaMed, the Advanced Medical Technology Association, released the following statement upon passage of the “fiscal cliff” legislation:
“The effort to repeal the medical device tax will continue. The passage of a scaled-back fiscal cliff package that did not address the medical device tax does not diminish the need to repeal the tax. It also does not diminish the bipartisan support for the repeal effort, which is premised on the recognition that the tax is costing jobs and threatening patient care. We urge Congress to repeal the device tax as it returns to address the other pressing tax and budget issues facing the country, so that we can avoid going over the medical technology innovation cliff.
“We appreciate the efforts of Members on both sides of the aisle and on both sides of Capitol Hill and we will continue to work with them to get Congress to act as soon as possible.
“AdvaMed also is disappointed in the cuts to imaging and diabetes-related services that are a part of the package passed by Congress. We believe these cuts will hurt access to important technologies that Medicare beneficiaries depend upon.”
# # #
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.